
HeartSciences Inc. has secured its first commercial SaaS revenue agreement with St. Vincent Health to deploy its MyoVista Insights platform, marking a key milestone from early adopter installations to revenue-generating deployments. MyoVista Insights is a cloud-based ECG management system that integrates AI to improve clinical workflows and is device-agnostic, designed to scale across healthcare facilities. The company expects more commercial agreements in the coming quarters as it gains market interest following its full launch at the American College of Cardiology Annual Scientific Session. This deal highlights HeartSciences' transition to mainstream commercial operations and its potential growth in healthcare technology adoption.